(Q48713004)

14 February 2018

title

Immunopathology of secondary-progressive multiple sclerosis. (English)

1 reference

14 February 2018

secondary progressive multiple sclerosis

main subject

0 references

0 references

7

1 reference

14 February 2018

Emilia L Oleszak

6

object named as

Oleszak EL

1 reference

14 February 2018

author name string

Prineas JW

1

1 reference

14 February 2018

Kwon EE

2

1 reference

14 February 2018

Cho ES

3

1 reference

14 February 2018

Sharer LR

4

1 reference

14 February 2018

Barnett MH

5

1 reference

14 February 2018

Morgan BP

8

1 reference

14 February 2018

publication date

1 November 2001

1 reference

14 February 2018

published in

Annals of Neurology

1 reference

14 February 2018

volume

50

1 reference

14 February 2018

page(s)

646-657

1 reference

14 February 2018

issue

5

1 reference

14 February 2018

Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis.

cites work

1 reference

The longstanding MS lesion. A quantitative MRI and electron microscopic study

21 January 2018

1 reference

Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study.

21 January 2018

1 reference

Axonal damage in acute multiple sclerosis lesions.

21 January 2018

1 reference

Axonal transection in the lesions of multiple sclerosis

21 January 2018

1 reference

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

21 January 2018

1 reference

Axonal pathology in myelin disorders

21 January 2018

1 reference

Microglia in degenerative neurological disease.

21 January 2018

1 reference

Monocyte/macrophage differentiation in early multiple sclerosis lesions.

21 January 2018

1 reference

On classification of post-mortem multiple sclerosis plaques for neuroscientists.

21 January 2018

1 reference

Further ultrastructural observations of virus morphogenesis and myelin pathology in JHM virus encephalomyelitis

21 January 2018

1 reference

Reactive microglia in multiple sclerosis lesions have an increased expression of receptors for the Fc part of IgG.

21 January 2018

1 reference

Opsonization of normal myelin by anti-myelin antibodies and normal serum

21 January 2018

1 reference

Macrophage phagocytosis of myelin in vitro determined by flow cytometry: phagocytosis is mediated by CR3 and induces production of tumor necrosis factor-alpha and nitric oxide.

21 January 2018

1 reference

Activation of adult human derived microglia by myelin phagocytosis in vitro

21 January 2018

1 reference

Biochemistry of demyelination

21 January 2018

1 reference

Complement potentiates the degradation of myelin proteins by plasmin: implications for a mechanism of inflammatory demyelination.

21 January 2018

1 reference

Proteolytic enzyme activity of blood leukocytes and cerebrospinal fluid in multiple sclerosis

21 January 2018

1 reference

Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein.

21 January 2018

1 reference

Demyelination in primate autoimmune encephalomyelitis and acute multiple sclerosis lesions: a case for antigen-specific antibody mediation.

21 January 2018

1 reference

Sera from MS patients and normal controls opsonize myelin

21 January 2018

1 reference

Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination

21 January 2018

1 reference

Multiple sclerosis: in situ evidence for antibody- and complement-mediated demyelination.

21 January 2018

1 reference

Complement activation by isolated myelin: activation of the classical pathway in the absence of myelin-specific antibodies

21 January 2018

1 reference

The instructive role of innate immunity in the acquired immune response

21 January 2018

1 reference

Complement activation by beta-amyloid in Alzheimer disease

21 January 2018

1 reference

Neurofibrillary tangles of Guam parkinson-dementia are associated with reactive microglia and complement proteins.

21 January 2018

1 reference

The complex of microglial cells and amyloid star in three-dimensional reconstruction.

21 January 2018

1 reference

Biotechnological agents for the immunotherapy of multiple sclerosis. Principles, problems and perspectives

21 January 2018

1 reference

Expression of transforming growth factor (TGF)-beta1, -beta2, and -beta3 isoforms and TGF-beta type I and type II receptors in multiple sclerosis lesions and human adult astrocyte cultures.

21 January 2018

1 reference

The pathophysiology of acute optic neuritis. An association of gadolinium leakage with clinical and electrophysiological deficits.

21 January 2018

1 reference

The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion.

21 January 2018

1 reference

A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases

21 January 2018

1 reference

Multiple sclerosis: a role for astroglia in active demyelination suggested by class II MHC expression and ultrastructural study

21 January 2018

1 reference

Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopy

21 January 2018

1 reference

The Expression of Tissue-type Plasminogen Activator, Matrix Metalloproteases and Endogenous Inhibitors in the Central Nervous System in Multiple Sclerosis

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/ANA.1255

1 reference

14 February 2018

PubMed ID

11706971

1 reference

14 February 2018